CVR: 43055909
Previous names: Ouisa Pharma ApS
DKK -10,204,929
Gross profit
Net result: DKK -12,777,761
JLSa2 Therapeutics, Inc.
CVR · view ownership and management
Owner registered: JLSa2 Therapeutics, Inc.
CVR · 31/07/2026
View the full event history
Ousia Pharma ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Ouisa Pharma ApS. The management consists of Christoffer Clemmensen, Jonas Odgaard Petersen and Anders Bue Klein. The company is owned by JLSa2 Therapeutics, Inc.. In 2025, the company reported a gross profit of DKK -10,204,929 and a net result of DKK -12,777,761 compared with DKK -5,348,579 the year before. Equity in the 2025 report amounted to DKK 11,818,220.
Formål er at udvikle nye lægemiddelkandidater til behandling af kroniske sygdomme.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -10.2 mio. | -12.8 mio. | 12.5 mio. | 11.8 mio. | 8 | |
| 202401/01/2024 – 31/12/2024 | -3.7 mio. | -5.3 mio. | 5.1 mio. | -10.1 mio. | 6 | |
| 202301/01/2023 – 31/12/2023 | -2.2 mio. | -3.7 mio. | 5.8 mio. | -4.7 mio. | 5 | |
| 202214/02/2022 – 31/12/2022 | -645 t. | -904 t. | 3.3 mio. | -864 t. | 3 |
Compared to 1.041 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningOusia Pharma ApS was founded on 14 February 2022.
Ousia Pharma ApS is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
Ousia Pharma ApS is owned by JLSa2 Therapeutics, Inc..
In 2025, Ousia Pharma ApS reported a gross profit of DKK -10,204,929.
The management of Ousia Pharma ApS consists of Christoffer Clemmensen, Jonas Odgaard Petersen and Anders Bue Klein.
Ousia Pharma ApS is located at Ole Maaløes Vej 3, 2200 København N.
Claim this page to add your logo and social links. Free to get started.
As of July 31, 2026, Gaurav Gupta has joined the board of directors of Ousia Pharma ApS.
As of July 31, 2026, Ramesh Rajanikant Bhatt has joined the board of directors of Ousia Pharma ApS.
As of July 31, 2026, Ian Rodney Laquian has left the board of directors of Ousia Pharma ApS.
As of July 31, 2026, Christoffer Clemmensen has left the board of directors of Ousia Pharma ApS.
As of July 31, 2026, Margareta Elisabeth Björk has left the board of directors of Ousia Pharma ApS.
As of July 31, 2026, is registered as an owner of Ousia Pharma ApS with an ownership share of 100%.
Ousia Pharma ApS has published its annual report for 2025. Gross profit came to DKK -10,204,929, and the net result was DKK -12,777,761.
Ousia Pharma ApS has published its annual report for 2024. Gross profit came to DKK -3,655,869, and the net result was DKK -5,348,579.
As of March 27, 2025, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Ousia Pharma ApS.
As of March 27, 2025, Menelas Nicolas Pangalos has joined the board of directors of Ousia Pharma ApS.
As of March 27, 2025, Otello Stampacchia has joined the board of directors of Ousia Pharma ApS.
As of March 27, 2025, Margareta Elisabeth Björk has joined the board of directors of Ousia Pharma ApS.
As of March 27, 2025, Mikael Søndergaard Thomsen has left the board of directors of Ousia Pharma ApS.
As of March 27, 2025, Jeppe Ragnar Andersen has left the board of directors of Ousia Pharma ApS.
As of March 27, 2025, Morten Peltola Toft has left the board of directors of Ousia Pharma ApS.
As of March 27, 2025, Jonas Odgaard Petersen has left the board of directors of Ousia Pharma ApS.
As of March 27, 2025, Anders Bue Klein has left the board of directors of Ousia Pharma ApS.
Ousia Pharma ApS has published its annual report for 2023. Gross profit came to DKK -2,239,754, and the net result was DKK -3,746,803.
Ousia Pharma ApS has published its interim report for the period February 14, 2022 – December 31, 2022.
As of February 14, 2023, Ian Rodney Laquian has joined the board of directors of Ousia Pharma ApS.
As of February 14, 2023, Mikael Søndergaard Thomsen has joined the board of directors of Ousia Pharma ApS.
As of February 14, 2023, Jeppe Ragnar Andersen has joined the board of directors of Ousia Pharma ApS.
As of February 14, 2023, Morten Peltola Toft has joined the board of directors of Ousia Pharma ApS.
As of February 14, 2023, Christoffer Clemmensen has joined the board of directors of Ousia Pharma ApS.
As of February 14, 2023, Jonas Odgaard Petersen has joined the board of directors of Ousia Pharma ApS.
As of February 14, 2023, Anders Bue Klein has joined the board of directors of Ousia Pharma ApS.
On February 22, 2022, the company changed its name from Ouisa Pharma ApS to Ousia Pharma ApS.
As of February 14, 2022, Christoffer Clemmensen is registered as director of Ousia Pharma ApS.
As of February 14, 2022, Jonas Odgaard Petersen is registered as director of Ousia Pharma ApS.
As of February 14, 2022, Anders Bue Klein is registered as director of Ousia Pharma ApS.
Ousia Pharma ApS was founded on February 14, 2022.
Companies in the same industry and area
CVR 45436497
CVR 46543912
CVR 44478587
CVR 31427169
CVR 43506242
